Compound for treating respiratory syncytial virus infection and preparation method and use thereof
The present invention declares a kind of compound to treat respiratory syncytial virus infection and its preparation method and application. The compound stated is cyclopamine's chemical analogs, has the property of inhibiting respiratory syncytial virus replication, and does not have the property of inhibiting Hedgehog signaling pathways. The preparation method stated is to get the cyclopamine's chemical analogs through drug chemical synthesis, then to screen the analogs with two parallel in vitro experiment. The compound described can be used to treat respiratory virus infection, paramyxovirus, respiratory syncytial virus infection, capillary bronchitis/pneumonia/tympanitis caused by respiratory syncytial virus. Furthermore, the compound described never cause the side effects of fetal malformation, and it overcame the teratogenicity of cyclopamine, and filled the gap of anti-human respiratory syncytial virus drug, especially of the field of pediatric drug.
1. A compound for treating a respiratory syncytial virus infection according to the following structure:
2. A method of treating a respiratory tract infection in a patient comprising administering to the patient the compound of claim 1 , wherein the compound does not cause side effects on the patient.
3. The method of claim 2 , wherein the respiratory tract infection is caused by a virus.
4. The method of claim 2 , wherein the respiratory tract infection is a paramyxovirus infection.
5. The method of claim 2 , wherein the respiratory tract infection is a respiratory syncytial virus infection.
6. The method of claim 2 , wherein the respiratory tract infection is capillary bronchitis caused by a respiratory syncytial virus.
7. The method of claim 2 , wherein the respiratory tract infection is pneumonia caused by a respiratory syncytial virus.
8. The method of claim 2 , wherein the respiratory tract infection is tympanitis caused by a respiratory syncytial virus.